We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-13.3%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$580M
AUM Growth
-$257M
Cap. Flow
-$134M
Cap. Flow %
-23.05%
Top 10 Hldgs %
37.84%
Holding
94
New
2
Increased
24
Reduced
33
Closed
31

Top Buys

Rank Stock Value
1
WMGI
Wright Medical Group Inc
WMGI
+$13.2M
2
INSP icon
Inspire Medical Systems
INSP
+$9.36M
3
IRTC icon
iRhythm Holdings
IRTC
+$7.84M
4
IMMU
Immunomedics Inc
IMMU
+$7.22M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$7.21M

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$36.8M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$17.3M
3
APLS
Apellis Pharmaceuticals
APLS
+$13.6M
4
AGN
Allergan plc
AGN
+$12M
5
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 83.54%
2 Industrials 3.13%
3 Technology 2.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
26
BioMarin Pharmaceuticals
BMRN
$12B
$9.56M 1.65%
141,801
-11,300
-7% -$870K
CI icon
27
Cigna
CI
$79.6B
$9.47M 1.63%
62,413
+15,100
+32% +$2.46M
HRC
28
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$9.27M 1.6%
88,099
-70,700
-45% -$7.46M
ZBH icon
29
Zimmer Biomet
ZBH
$18.5B
$9.14M 1.58%
68,596
+16,480
+32% +$2.13M
BSX icon
30
Boston Scientific
BSX
$68.5B
$9.04M 1.56%
222,176
-4,400
-2% -$186K
XLRN
31
DELISTED
Acceleron Pharma
XLRN
$8.99M 1.55%
227,596
-41,800
-16% -$1.81M
RCM
32
DELISTED
R1 RCM Inc. Common Stock
RCM
$8.84M 1.52%
989,572
-89,300
-8% -$1.05M
MDT icon
33
Medtronic
MDT
$111B
$7.89M 1.36%
72,651
-4,200
-5% -$438K
ABT icon
34
Abbott
ABT
$187B
$7.3M 1.26%
87,198
+4,000
+5% +$340K
ASMB icon
35
Assembly Biosciences
ASMB
$507M
$7.08M 1.22%
59,991
-10,650
-15% -$1.61M
STML
36
DELISTED
Stemline Therapeutics, Inc.
STML
$7.05M 1.22%
677,759
+11,601
+2% +$152K
TRHC
37
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$6.63M 1.14%
+120,600
New +$6.9M
PFE icon
38
Pfizer
PFE
$144B
$6.59M 1.14%
193,439
-189,086
-49% -$6.88M
SRPT icon
39
Sarepta Therapeutics
SRPT
$1.63B
$6.36M 1.1%
84,398
-32,699
-28% -$3.86M
LLY icon
40
Eli Lilly
LLY
$1.09T
$6.24M 1.08%
55,765
-50,900
-48% -$5.67M
OBSV
41
DELISTED
ObsEva SA Ordinary Shares
OBSV
$5.36M 0.92%
643,151
– –
TMO icon
42
Thermo Fisher Scientific
TMO
$214B
$5.3M 0.91%
18,200
+14,750
+428% +$4.22M
FTSV
43
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$5.23M 0.9%
814,414
+157,763
+24% +$1.3M
CHNG
44
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$4.9M 0.85%
405,750
-44,800
-10% -$615K
EVLO
45
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$4.47M 0.77%
36,629
+3,160
+9% +$434K
VRAY
46
DELISTED
ViewRay, Inc.
VRAY
$3.6M 0.62%
1,240,865
+169,600
+16% +$1M
ALXN
47
DELISTED
Alexion Pharmaceuticals
ALXN
$3.59M 0.62%
36,699
-36,500
-50% -$4.11M
MGTX icon
48
MeiraGTx Holdings
MGTX
$1.09B
$3.27M 0.57%
205,306
-20,600
-9% -$479K
ALBO
49
DELISTED
Albireo Pharma Inc
ALBO
$2.94M 0.51%
147,211
-95,767
-39% -$2.48M
HMSY
50
DELISTED
HMS Holdings Corp.
HMSY
$2.68M 0.46%
77,725
-233,553
-75% -$8.44M
1
2
3 4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Sectoral Asset Management held 94 positions worth $580M, down 31% from $836M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sectoral Asset Management withdrew a net $134M in Q3 2019, closing 31 positions and reducing 33 holdings. Its most notable exit was Array Biopharma Inc, an estimated $36.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Industrials and Technology.

Against the trend, Sectoral Asset Management opened a new position in Tabula Rasa HealthCare, Inc. Common Stock worth $6.63M.

  • Sectoral Asset Management's largest Q3 2019 buy was Tabula Rasa HealthCare, Inc. Common Stock: 120,600 shares worth $6.63M.
  • Sectoral Asset Management added most to Wright Medical Group Inc in Q3 2019, an estimated $13.2M increase.
  • Sectoral Asset Management's biggest Q3 2019 reduction was Alnylam Pharmaceuticals, cutting an estimated $17.3M.
  • Sectoral Asset Management fully exited Array Biopharma Inc in Q3 2019, selling an estimated $36.8M.
  • Sectoral Asset Management's ten largest holdings make up 38% of its $580M portfolio in Q3 2019.
  • Sectoral Asset Management opened 2 new positions and closed 31 in Q3 2019.
  • Sectoral Asset Management's portfolio value fell 31% quarter-over-quarter to $580M.

Based on Sectoral Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.